A time antibody injection against RSV is available for infants in some countries
Shuttertock / anatta_tan
An antibon drug for respiratory syncytial virus (RSV) appears more effective in protecting infants from severe disease than Home vaccination.
About 100,000 children Around the world under the age of 5 dies from RSV per year. Now, there is only Two ways to vaccinate infants against the virus. The first is a vaccine given during pregnancy, which passes the antibodies of the fetus and protects children for the first six months of life. The second one an instance of injection of antibodycalled Beyfortus, ministered to the children shortly during their first time RSV or within a week after childbirth.
Both therapies available recently. For example, US food has been approved and dominated the administration of the root For children on July 2023 and the mother vaccine A month later. The therapists were approved elsewhere, including Australia, Japan and several European countries.
Oliver Martyn In the French Pharmaceutical Company Sanafi and his companions used in real-world data to better understand the effectiveness of each method. Santofi made Beyfeus in collaboration with UK Biotechnology Company Astrazeneca.
Researchers analyze Hospital Rate in UK and Spain in 1 year old and younger than June 2022 and May 2025. Time to care for maternal RSVs to protect infants. Meanwhile, Spain only offers Beyfortus by its public health care system; The mother’s care vehicle vaccine can be bought there by private prescription.
Breast Hospitalizations have dropped 69 percent of Spain during 2024 to 2025 period compared to 2022 to 2023 times, if it does not apply to hike. Rates reduced almost 27 percent in the UK at the same time. Search, Martyn presented a 29 May meeting of the European Society Society for diseased Romanian diseases from the mother-vaccination than the mother vaccination than the vaccination of antvs than the immunization of antvs than severe r
However, direct comparison between two countries is difficult, given to their populations and health care systems will vary. For example, Spain began to serve the babe in 2023 while the UK launched the mother’s vaccination program at 2024. That there was also times in the year of coveness than that of the year.
The study also included infants that mothers cannot be made for the UK vocination “and thus, a pfizer spokesman, the biotechnology vaccine that the US develops the US vaccine.
“You have to take these outcomes of a grain of salt,” as Jennifer Duchon In the Medicine School of Icahn on Mount Sinai in New York, with many reasons to develop the hepeonalizations between two countries. “(Most) data we are currently, including clinical trials, shows that, especially in the youngest infants, for the worst outcome, the most serious consequences,” he said.
Topics:
